Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study
Hélène-Antoine Poirel(Hôpital Avicenne), Catherine Patte(Institut Gustave Roussy), Richard Sposto(Children's Hospital of Los Angeles), Martine Raphaël(University of Lausanne), Erika Launay(Université Sorbonne Paris Nord), Mary Gerrard(Sheffield Children's Hospital), Keith McCarthy(National Health Service), Alain Bernheim(Triemli Hospital), Warren G. Sanger, Nyla A. Heerema(The Ohio State University), S L Perkins(University of Utah), A. Aupérin(Inserm), Mitchell S. Cairo(New York Medical College), P. Talley(Sheffield Children's Hospital), John Swansbury(Royal Marsden Hospital)
Cited by 134
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934